Numinus Wellness, Inc. (NUMIF)
0.0216
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Numinus Wellness Net Income (Quarterly) : -0.4755M for May 31, 2025
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2025 | -0.4755M |
| February 28, 2025 | -6.559M |
| November 30, 2024 | -0.7597M |
| May 31, 2024 | -2.846M |
| February 29, 2024 | -3.605M |
| November 30, 2023 | -2.758M |
| August 31, 2023 | -7.005M |
| May 31, 2023 | -5.097M |
| February 28, 2023 | -5.436M |
| November 30, 2022 | -4.669M |
| August 31, 2022 | -19.15M |
| May 31, 2022 | -5.512M |
| February 28, 2022 | -6.165M |
| November 30, 2021 | -4.262M |
| August 31, 2021 | -6.251M |
| May 31, 2021 | -3.890M |
| February 28, 2021 | -3.324M |
| November 30, 2020 | -1.464M |
| August 31, 2020 | -2.451M |
| May 31, 2020 | -2.378M |
| January 31, 2020 | -0.0884M |
| October 31, 2019 | -0.0346M |
| July 31, 2019 | -0.0567M |
| April 30, 2019 | -0.024M |
| January 31, 2019 | -0.0362M |
| Date | Value |
|---|---|
| October 31, 2018 | -0.0143M |
| July 31, 2018 | -0.0817M |
| April 30, 2018 | -0.0851M |
| January 31, 2018 | -0.066M |
| October 31, 2017 | 0.0156M |
| July 31, 2017 | -0.1318M |
| April 30, 2017 | 0.027M |
| January 31, 2017 | -0.0455M |
| October 31, 2016 | -0.0465M |
| July 31, 2016 | -0.0446M |
| April 30, 2016 | -0.0304M |
| January 31, 2016 | -0.0351M |
| October 31, 2015 | -1.392M |
| July 31, 2015 | -0.0093M |
| April 30, 2015 | -0.123M |
| January 31, 2015 | -0.0578M |
| October 31, 2014 | -0.0382M |
| July 31, 2014 | -0.1287M |
| April 30, 2014 | -0.2103M |
| January 31, 2014 | -0.1823M |
| October 31, 2013 | -0.2101M |
| July 31, 2013 | -0.5506M |
| April 30, 2013 | -0.0515M |
| January 31, 2013 | -0.1186M |
| October 31, 2012 | -0.064M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -2.299M |
| Edesa Biotech, Inc. | -4.218M |
| CNBX Pharmaceuticals, Inc. | -0.0441M |
| GB Sciences, Inc. | -- |
| ProMIS Neurosciences, Inc. | -8.244M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.282M |
| Total Expenses (Quarterly) | 1.758M |
| EPS Diluted (Quarterly) | -0.0017 |